All Stories

  1. Targeted Liposome Garcinol Formulation for the Treatment of Colon Cancer: Pharmacological and Toxicological Evaluation

    Article • ACS Applied Bio Materials, September 2025, American Chemical Society (ACS)

    Ramesh Kandimalla

  2. Bridging knowledge gaps: impact of remedial classes on first-year medical students in biochemistry – a cross-sectional study

    Article • BMC Medical Education, November 2024, Springer Science + Business Media

    Ramesh Kandimalla

  3. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders

    Article • Journal of Drug Delivery Science and Technology, January 2024, Elsevier

    Ramesh Kandimalla

  4. Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive Review

    Article • Cellular and Molecular Neurobiology, December 2023, Springer Science + Business Media

    Ramesh Kandimalla

  5. Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies

    Article • Journal of Drug Delivery Science and Technology, November 2023, Elsevier

    Ramesh Kandimalla

  6. Optical detection of bovine serum albumin using charged cholesteric liquid crystal droplets functionalized with surfactant

    Article • Journal of Molecular Liquids, September 2023, Elsevier

    Ramesh Kandimalla

  7. CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges

    Article • Drug Discovery Today, August 2023, Elsevier

    Leena Chacko, Ramesh Kandimalla

  8. Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks

    Article • May 2023, Wiley

    Ramesh Kandimalla

  9. Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies

    Article • Biomedicines, April 2023, MDPI AG

    Leena Chacko, Ramesh Kandimalla

  10. Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity

    Article • Biomedicines, June 2022, MDPI AG

    Ramesh Kandimalla

  11. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2

    Article • PeerJ, March 2022, PeerJ

    Dr Amos Lal, Ramesh Kandimalla

  12. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

    Article • Cells, November 2021, MDPI AG

    Ramesh Kandimalla

  13. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges

    Article • Biomedicines, November 2021, MDPI AG

    Ramesh Kandimalla

  14. Potential Biomarkers Associated with Multiple Sclerosis Pathology

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Ramesh Kandimalla

  15. COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?

    Article • Biomolecules, July 2021, MDPI AG

    Ángel Serrano Aroca, Dr Amos Lal, Ramesh Kandimalla

  16. Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy

    Article • Ageing Research Reviews, July 2021, Elsevier

    Ramesh Kandimalla

  17. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic

    Article • Molecular Neurobiology, June 2021, Springer Science + Business Media

    Ramesh Kandimalla

  18. Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice

    Article • Mitochondrion, February 2021, Elsevier

    Dr., Pradeepkiran Jangampalli Adi, Ramesh Kandimalla

  19. Mitochondrial dysfunction, mitophagy, and role of dynamin‐related protein 1 in Alzheimer's disease

    Article • Journal of Neuroscience Research, January 2021, Wiley

    Ramesh Kandimalla

  20. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features

    Article • Molecules, December 2020, MDPI AG

    Ángel Serrano Aroca, Ramesh Kandimalla

  21. The Importance of Research on the Origin of SARS-CoV-2

    Article • Viruses, October 2020, MDPI AG

    Ramesh Kandimalla

  22. Potential Pathological Biomarkers in Multiple Sclerosis

    Article • September 2020, MDPI AG

    Ramesh Kandimalla

  23. Screening of potential drug for Alzheimer’s disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation

    Article • Journal of Biomolecular Structure and Dynamics, August 2020, Taylor & Francis

    Ramesh Kandimalla

  24. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings

    Article • Pathogens, July 2020, MDPI AG

    Ramesh Kandimalla

  25. Cell cycle activation in p21 dependent pathway: An alternative mechanism of organophosphate induced dopaminergic neurodegeneration

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, July 2017, Elsevier

    Ramesh Kandimalla

  26. Dynamics of diabetes and obesity: Epidemiological perspective

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, May 2017, Elsevier

    Ramesh Kandimalla

  27. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, May 2017, Elsevier

    Ramesh Kandimalla

  28. Therapeutics of Neurotransmitters in Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, April 2017, IOS Press

    Ramesh Kandimalla

  29. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease

    Article • Human Molecular Genetics, April 2017, Oxford University Press (OUP)

    Ramesh Kandimalla

  30. Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Ramesh Kandimalla, Madhu Sudhana Saddala, Dr., Pradeepkiran Jangampalli Adi, Dr Pradeepkiran Jangampalli Adi

  31. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease

    Article • Human Molecular Genetics, February 2017, Oxford University Press (OUP)

    Ramesh Kandimalla

  32. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease

    Article • Biochemical and Biophysical Research Communications, February 2017, Elsevier

    Ramesh Kandimalla

  33. MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease

    Article • January 2017, Elsevier

    Ramesh Kandimalla

  34. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease

    Article • Human Molecular Genetics, September 2016, Oxford University Press (OUP)

    Ramesh Kandimalla

  35. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease

    Article • Human Molecular Genetics, September 2016, Oxford University Press (OUP)

    Ramesh Kandimalla

  36. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease

    Article • Journal of Investigative Medicine, August 2016, BMJ

    Ramesh Kandimalla

  37. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus

    Article • Neuroscience, June 2016, Elsevier

    Ramesh Kandimalla

  38. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2016, Elsevier

    Ramesh Kandimalla

  39. Aluminum and Alzheimer's disease

    Article • Brain Pathology, December 2015, Wiley

    Ramesh Kandimalla

  40. Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, September 2015, IOS Press

    Ramesh Kandimalla

  41. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    Article • JAMA, May 2015, American Medical Association (AMA)

    Ramesh Kandimalla

  42. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer

    Article • Cancer Letters, February 2015, Elsevier

    Ramesh Kandimalla

  43. CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease

    Article • Current Alzheimer Research, April 2014, Bentham Science Publishers

    Ramesh Kandimalla

  44. Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3mesoporous particles

    Article • Dalton Transactions, January 2014, Royal Society of Chemistry

    Ramesh Kandimalla

  45. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation

    Article • Neuroscience, January 2014, Elsevier

    Ramesh Kandimalla

  46. Aluminium induced oxidative stress results in decreased mitochondrial biogenesis via modulation of PGC-1α expression

    Article • Toxicology and Applied Pharmacology, December 2013, Elsevier

    Ramesh Kandimalla

  47. CSF p-Tau levels in the prediction of Alzheimer's disease

    Article • Biology Open, September 2013, The Company of Biologists

    Ramesh Kandimalla

  48. PEGylated α-Gd2(MoO4)3Mesoporous Flowers: Synthesis, Characterization, and Biological Application

    Article • Crystal Growth & Design, September 2013, American Chemical Society (ACS)

    Ramesh Kandimalla

  49. Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease

    Article • American Journal of Alzheimer s Disease & Other Dementias®, May 2013, SAGE Publications

    Ramesh Kandimalla

  50. Effect of Resveratrol and Nicotine on PON1 Gene Expression: In Vitro Study

    Article • Indian Journal of Clinical Biochemistry, February 2013, Springer Science + Business Media

    Ramesh Kandimalla

  51. Quercetin Protects Against Chronic Aluminum-Induced Oxidative Stress and Ensuing Biochemical, Cholinergic, and Neurobehavioral Impairments in Rats

    Article • Neurotoxicity Research, August 2012, Springer Science + Business Media

    Ramesh Kandimalla

  52. siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells

    Article • Journal of Biomedical Science, January 2012, Springer Science + Business Media

    Ramesh Kandimalla

  53. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain

    Article • Neuropharmacology, December 2011, Elsevier

    Ramesh Kandimalla

  54. Protective Efficacy of Coenzyme Q10 Against DDVP-Induced Cognitive Impairments and Neurodegeneration in Rats

    Article • Neurotoxicity Research, November 2011, Springer Science + Business Media

    Ramesh Kandimalla

  55. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population

    Article • Gene, November 2011, Elsevier

    Ramesh Kandimalla

  56. Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients

    Article • Neuroscience Letters, January 2011, Elsevier

    Ramesh Kandimalla

  57. Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes

    Article • Molecular Brain, November 2010, Springer Science + Business Media

    Ramesh Kandimalla

  58. Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos

    Article • Toxicology, April 2010, Elsevier

    Ramesh Kandimalla